E-LIB Suche - Ergebnisse für: Ascierto, P.A.

1

Interim analysis of the multinational, post-authorisation s..:

Gutzmer, R. ; Mohr, P. ; Kähler, K....
EJC Skin Cancer. 2 (2024) - p. 100044 , 2024

Link: https://doi.org/10.1016/..

2

Gene Signatures predict immune-related skin adverse events ..:

Mallardo, D. ; Fordellone, M. ; Bailey, M....
EJC Skin Cancer. 2 (2024) - p. 100124 , 2024

Link: https://doi.org/10.1016/..

3

Merkel-cell carcinoma: ESMO–EURACAN Clinical Practice Guide..:

Lugowska, I. ; Becker, J.C. ; Ascierto, P.A....
ESMO Open. 9 (2024) 5 - p. 102977 , 2024

Link: https://doi.org/10.1016/..

4

Combinatorial immune checkpoint blockade increases myocardi..:

Quagliariello, V. ; Passariello, M. ; Bisceglia, I....
Frontiers in Cardiovascular Medicine. 11 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

5

33P Impact of prior treatment on baseline immune biomarkers..:

Ascierto, P.A. ; Tang, H. ; Dolfi, S....
Immuno-Oncology and Technology. 20 (2023) - p. 100502 , 2023

Link: https://doi.org/10.1016/..

6

70MO Genomic profiling to expand precision cancer medicine ..:

Botticelli, A. ; Scagnoli, S. ; Conte, P.F....
ESMO Open. 8 (2023) 1 - p. 100928 , 2023

Link: https://doi.org/10.1016/..

7

Biomarkers of treatment benefit with atezolizumab plus vemu..:

Robert, C. ; Lewis, K.D. ; Gutzmer, R....
Annals of Oncology. 33 (2022) 5 - p. 544-555 , 2022

Link: https://doi.org/10.1016/..

8

Pembrolizumab in microsatellite instability high or mismatc..:

Maio, M. ; Ascierto, P.A. ; Manzyuk, L....
Annals of Oncology. 33 (2022) 9 - p. 929-938 , 2022

Link: https://doi.org/10.1016/..

9

Drug-induced interstitial lung disease during cancer therap..:

Conte, P. ; Ascierto, P.A. ; Patelli, G....
ESMO Open. 7 (2022) 2 - p. 100404 , 2022

Link: https://doi.org/10.1016/..

10

How we treat locoregional melanoma:

Troiani, T. ; De Falco, V. ; Napolitano, S...
ESMO Open. 6 (2021) 3 - p. 100136 , 2021

Link: https://doi.org/10.1016/..

11

Nivolumab (NIVO) vs ipilimumab (IPI) en traitement adjuvant..:

Weber, J. ; Del Vecchio, M. ; Mandalá, M....
Annales de Dermatologie et de Vénéréologie. 147 (2020) 12 - p. A78-A79 , 2020

Link: https://doi.org/10.1016/..

12

Identification of cases and estimate of direct costs of unr..:

Ronconi, G. ; Piccinni, C. ; Dondi, L....
British Journal of Dermatology. 183 (2020) 1 - p. 172-174 , 2020

Link: https://doi.org/10.1111/..

13

Sonidegib and vismodegib in the treatment of patients with ..:

Dummer, R. ; Ascierto, P.A. ; Basset‐Seguin, N....
Journal of the European Academy of Dermatology and Venereology. 34 (2020) 9 - p. 1944-1956 , 2020

Link: https://doi.org/10.1111/..

14

PCN40 Healthcare Resource Utilization in Patients Treated w..:

Mandala, M. ; Arance, A. ; Dummer, R....
Value in Health. 23 (2020) - p. S428 , 2020

Link: https://doi.org/10.1016/..

15

Nivolumab (NIVO) versus ipilimumab (IPI) dans le traitement..:

Grob, J.-J. ; Weber, J. ; Del Vecchio, M....
Annales de Dermatologie et de Vénéréologie. 146 (2019) 12 - p. A102-A103 , 2019

Link: https://doi.org/10.1016/..